NCT00273039 - A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder | Biotech Hunter

Enrollment

242

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions

Social Anxiety DisorderAnxiety Disorders

Interventions

DRUG

paroxetine

Trial Locations (27)

5000

GSK Investigational Site, Córdoba

10021

GSK Investigational Site, New York

10024

GSK Investigational Site, New York

19149

GSK Investigational Site, Philadelphia

20852

GSK Investigational Site, Rockville

30080

GSK Investigational Site, Smyrna

32216

GSK Investigational Site, Jacksonville

32806

GSK Investigational Site, Orlando

33125

GSK Investigational Site, Miami

33161

GSK Investigational Site, North Miami

60181

GSK Investigational Site, Oakbrook Terrace

64170

GSK Investigational Site, Monterrey

73104

GSK Investigational Site, Oklahoma City

77566

GSK Investigational Site, Lake Jackson

90210

GSK Investigational Site, Beverly Hills

91506

GSK Investigational Site, Burbank

7500710

GSK Investigational Site, Providencia / Santiago

7580208

GSK Investigational Site, Santiago

C1122AAN

GSK Investigational Site, Buenos Aires

B1896AEH

GSK Investigational Site, La Plata/Buenos Aires

C1062ABF

GSK Investigational Site, Buenos Aires

T6L 5X8

GSK Investigational Site, Edmonton

V1Y 2H4

GSK Investigational Site, Kelowna

E1V 3G5

GSK Investigational Site, Miramichi

Unknown

GSK Investigational Site, San José

03740

GSK Investigational Site, Mexico City